SK
Sushil Kumar
About Sushil Kumar
Sushil Kumar has 21 years in corporate governance. Holds Additional Director and Director roles. Currently with 2 companies, including Redvaxin Private Limited and Supritech Solutions Private Limited. Formerly with 2 companies, such as Loren Health Care Private Limited and Perron Pharmaceuticals Private Limited. Engaged in General Business, Technology and more.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Redvaxin Private Limited
U21001DL2020PTC365992
|
Additional Director | 16 Jun 2025 | 2020 | Active |
Supritech Solutions Private Limited
U62090UP2024PTC205561
|
Director | 29 Jun 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Loren Health Care Private Limited
U24232DL2005PTC138914
|
Director | 20 Jul 2005 | 2005 | Strike Off |
Perron Pharmaceuticals Private Limited
U24233DL2008PTC176181
|
Director | 01 Apr 2008 | 2008 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushil Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushil Kumar
Sushil Kumar has 21 years in corporate governance. Holds Additional Director and Director roles. Currently with 2 companies, including Redvaxin Private Limited and Supritech Solutions Private Limited. Formerly with 2 companies, such as Loren Health Care Private Limited and Perron Pharmaceuticals Private Limited. Engaged in General Business, Technology and more.
Sushil Kumar is associated with 2 companies as Additional Director and Director.
Sushil Kumar has expertise in General Business, Technology and other sectors.
Sushil Kumar has 21 years in corporate governance.